ÌÇÐÄvlog´«Ã½

Europe Incontinence Devices & Ostomy Market Analysis

The European incontinence devices and ostomy market are expected to register a CAGR of 10.1% during the forecast period.

COVID-19 had a significant impact on the growth of the market. This was due to the halt of visits to healthcare centers such as clinics and hospitals and the unavailability of proper treatment procedures. For instance, the research study published in Springer in March 2022 mentioned that, overall, a 19.5% reduction in ostomy closure occurred between March 2020 and February 2021. In such circumstances, patient care was delivered through telemedicine services in Europe. Additionally, in a research article published in Springer in August 2020 in Southern Italy, a telemedicine-based pathway was developed for emergency care outpatients with a colostomy as a response to the postponements of patient visits. Such delays in outpatient visits led to a short-term decline in the demand for incontinence and ostomy devices. However, the relaxation of the strict regulations in Europe led to the reopening of healthcare centers and an increase in patient inflow, thereby driving the demand for incontinence devices and ostomies and boosting the growth of the market over the forecast period.

Factors driving market growth include the rising geriatric and obese populations, the increasing prevalence of renal diseases and nephrological injuries, and the growing awareness and acceptance of ostomy care products.

According to a United Nations report published in 2022, by 2050, one in every four people in Europe will be 65 or older. Similarly, Italy has approximately 23.6% of its population aged 65 and older, according to the United Nations Population Fund's World Population Dashboard Statistics 2021. As the geriatric population becomes more vulnerable to kidney disorders, the demand for incontinence devices and ostomies is expected to rise, which is expected to contribute to the growth of the market studied. Additionally, the prevalence of renal disorders among the European population is expected to contribute to the growth of the market. As per the Lancet article published in June 2022, one in ten adults in Europe is likely to have chronic kidney disease. Similarly, as per the European Kidney Alliance report published in 2021, a staggering 75 million people suffer from chronic kidney disease in Europe. Such prevalence of chronic kidney disorders among the European population is expected to contribute to rising demand for Incontinence and ostomy devices in Europe, which is poised to drive market growth over the forecast period.

Thus, the aforementioned factors are expected to drive the growth of the market over the forecast period. However, the lack of proper reimbursement and complications associated with ostomy devices, and the usage of incontinence products are expected to restrain the growth of the market.

Europe Incontinence Devices & Ostomy Market Trends

This section covers the major market trends shaping the Europe Incontinence Devices & Ostomy Market according to our research experts:

Colorectal Cancer is Expected to Hold a Significant Share in the Growth of the Market Over the Forecast Period

Europe Incontinence Devices & Ostomy Industry Segmentation

As per the scope of the report, ostomy surgery is a procedure that allows bodily waste to pass through a surgically created stoma on the abdomen. Ostomy care products, such as skin barriers and ostomy bags, provide means for the collection of waste from a surgically diverted biological system. In incontinence, there is a lack of voluntary release of contents from the urinary bladder, for which several disposable incontinence products (DIP) are manufactured by the leading medical device companies. The Europe Incontinence Devices and Ostomy Market is Segmented by Product Type (Incontinence Care Products (Absorbents, Incontinence Bags, and Other Product Types) and Ostomy Care Products (Ostomy Bags (Colostomy Bags, Ileostomy Bags and Urostomy Bags), Skin Barriers, Irrigation Products, and Other Ostomy Products)), by Application (Bladder Cancer, Colorectal Cancer, Crohn's Disease, Kidney Stone, Chronic Kidney Failure, and Other Applications), and by Geography (Germany, United Kingdom, France, Italy, Spain, Rest of Europe). The report offers the value (in USD million) for the above segments.